Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

BACKGROUND: Phobic anxiety disorders are among the most prevalent psychiatric disorders and are burdensome in terms of loss of quality of life and work productivity. Evidence-based treatments are relatively successful in the majority of patients, especially exposure therapy. However, a substantial s...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Flier, Febe E., Kwee, Caroline M. B., Cath, Danielle C., Batelaan, Neeltje M., Groenink, Lucianne, Duits, Puck, van der Veen, Date C., van Balkom, Anton J. L. M., Baas, Johanna M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373100/
https://www.ncbi.nlm.nih.gov/pubmed/30760241
http://dx.doi.org/10.1186/s12888-019-2022-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373100/
https://www.ncbi.nlm.nih.gov/pubmed/30760241
http://dx.doi.org/10.1186/s12888-019-2022-x

Ejemplares similares